Magnetic Resonance Imaging Monitoring of Multiple Sclerosis Lesion Evolution
暂无分享,去创建一个
[1] G J Barker,et al. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. , 1999, Magnetic resonance imaging.
[2] J. McGowan,et al. The physical basis of magnetization transfer imaging. , 1999, Neurology.
[3] G. B. Pike Ph. D.,et al. Magnetization transfer imaging of multiple sclerosis , 2005, The Italian Journal of Neurological Sciences.
[4] M. Horsfield,et al. A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads , 1998, Journal of the Neurological Sciences.
[5] J. Pekar,et al. Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance , 1991, Journal of magnetic resonance imaging : JMRI.
[6] H. Powell,et al. Pathology of multiple sclerosis. , 1983, Neurologic clinics.
[7] F. Barkhof,et al. The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS , 2001, Neurology.
[8] N. Richert. Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". , 2002, Neurology.
[9] H F McFarland,et al. The lesion in multiple sclerosis: clinical, pathological, and magnetic resonance imaging considerations. , 1998, Journal of neurology, neurosurgery, and psychiatry.
[10] Robert Zivadinov,et al. Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[11] J. Babb,et al. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. , 2005, Radiology.
[12] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[13] F Barkhof,et al. Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.
[14] G J Barker,et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.
[15] R Stollberger,et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis , 2000, Magnetic resonance in medicine.
[16] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[17] J. Dawson,et al. The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.
[18] S W Atlas,et al. Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.
[19] Ponnada A Narayana,et al. Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[20] M W Weiner,et al. A serial study of new MS lesions and the white matter from which they arise , 1998, Neurology.
[21] P. Calabresi,et al. Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI , 1997, Neurology.
[22] J. Caillé,et al. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies , 1998, Neurology.
[23] P M Matthews,et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. , 1999, Brain : a journal of neurology.
[24] G J Barker,et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.
[25] D. Arnold,et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis , 2002, Journal of Neurology.
[26] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[27] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[28] J A Maldjian,et al. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. , 2000, AJNR. American journal of neuroradiology.
[29] R. Kikinis,et al. The evolution of multiple sclerosis lesions on serial MR. , 1995, AJNR. American journal of neuroradiology.
[30] G. Barker,et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.
[31] W. Hickey. Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation , 1991, Brain pathology.
[32] B E Kendall,et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.
[33] P. Matthews,et al. Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.
[34] M Cercignani,et al. Weekly diffusion-weighted imaging of normal-appearing white matter in MS , 2000, Neurology.
[35] R I Grossman,et al. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. , 1995, AJNR. American journal of neuroradiology.
[36] G. Comi,et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.
[37] P. Basser,et al. Diffusion tensor MR imaging of the human brain. , 1996, Radiology.
[38] C. Lucchinetti,et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions , 2001, Annals of neurology.
[39] R. Tarducci,et al. 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a: results of a preliminary study , 1998, Journal of neurology, neurosurgery, and psychiatry.
[40] O. Ciccarelli,et al. Magnetic resonance outcome of new enhancing lesions in patients with relapsing‐remitting multiple sclerosis , 1999, European Journal of Neurology.
[41] B E Kendall,et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.
[42] M. Filippi,et al. Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis , 1996, Neuroradiology.
[43] J. Frahm,et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.
[44] R I Grossman,et al. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. , 1996, AJNR. American journal of neuroradiology.
[45] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[46] P. Matthews,et al. Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.
[47] H I Goldberg,et al. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. , 1988, Radiology.
[48] J. Taubenberger,et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.
[49] F. Barkhof,et al. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.
[50] R. Grossman,et al. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. , 1995, AJNR. American journal of neuroradiology.
[51] C. Pozzilli,et al. Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.
[52] Simon K Warfield,et al. Diffusion Tensor Magnetic Resonance Imaging in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[53] S. Reingold,et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.
[54] R E Lenkinski,et al. MR proton spectroscopy in multiple sclerosis. , 1992, AJNR. American journal of neuroradiology.
[55] J. Dawson,et al. XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.
[56] F. Barkhof,et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.
[57] S. Majumdar,et al. Magnetization transfer ratio in new MS lesions before and during therapy with IFNβ-1a , 2000, Neurology.
[58] C. Elster,et al. Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.